Table 3.
Baseline characteristics of the participants.
| Variable | IG | CG | p | ||
|---|---|---|---|---|---|
| Mean ± SD | N | Mean ± SD | N | ||
| Characteristic | |||||
| Age | 75.61 ± 9.01 | 95 | 77.90 ± 8.84 | 96 | .100 |
| Gender | 96 | 97 | .705 | ||
| Males | 13.5% | 15.5% | |||
| Females | 86.5 | 94.5% | |||
| Education | 97 | 92 | .767 | ||
| Below primary | 92.8% | 94.6% | |||
| Above primary | 7.2% | 5.4% | |||
| Risk score | 7.92 ± 1.18 | 96 | 8.06 ± 1.06 | 97 | .370 |
| Assessment | |||||
| Total RBANS (T-scores) | 51.38 ± 9.66 | 89 | 49.22 ± 10.12 | 94 | .143 |
| Immediate memory | 51.43 ± 9.46 | 92 | 49.13 ± 9.94 | 96 | .106 |
| Visuospatial/constructional | 50.84 ± 9.7 | 91 | 49.38 ± 10.33 | 95 | .391 |
| Language | 51.34 ± 9.62 | 92 | 49.08 ± 10.04 | 96 | .117 |
| Attention | 50.58 ± 10.08 | 92 | 49.62 ± 10.04 | 96 | .498 |
| Delayed memory | |||||
| Total cholesterol | 174.7 ± 43.96 | 74 | 182.03 ± 39.42 | 80 | .186 |
| HDL | 53.24 ± 14.18 | 74 | 56.70 ± 16.86 | 83 | .114 |
| LDL | 99.14 ± 36.77 | 72 | 102.05 ± 35.01 | 79 | .577 |
| Triglycerides | 118.36 ± 52.55 | 73 | 119.11 ± 57.33 | 81 | .674 |
| Glucose | 110.15 ± 24.45 | 74 | 115.93 ± 47.34 | 82 | .352 |
| QoL VAS | 79.39 ± 17.26 | 92 | 81.01 ± 17.47 | 97 | .429 |
| QoL Index | 0.82 ± 0.21 | 93 | 0.83 ± 0.24 | 97 | .319 |
P value indicates statistical difference between Intervention Group (IG) and Control Group (CG).
Blood test unit of measure are in mg/dL.